Company Profiles

driven by the PitchBook Platform

Ariavax

Description

Developer of a vaccine against urinary tract infection. The company's vaccines are based on its proprietary peptide chemistry technology.

2000

Founded

PRIVATE

Status

Grant

Latest Deal Type

$556k

Latest Deal Amount

2

Investors

Description

Developer of a vaccine against urinary tract infection. The company's vaccines are based on its proprietary peptide chemistry technology.

Website:

www.ariavax.com

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Primary Office

708 Quince Orchard Road Gaithersburg, MD 20878United States +1 (240) 632-2789
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Ariavax's full profile, request a free trial.

    Ariavax Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Ariavax Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Maryland Industrial PartnershipsAccelerator/Incubator000 0000000 0000
    TEDCOVenture CapitalMinority000 0000000 0000
    Maryland Industrial Partnerships Accelerator/Incubator
    TEDCO Venture Capital
    Request full access to PitchBook